Form 8.3 Irish Residential 051126
Summary by AI BETAClose X
FORM 8.3
IRISH TAKEOVER PANEL
OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
|
(a) Full name of discloser |
Brewin Dolphin Wealth Management Limited |
|
(b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. |
|
|
(c) Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree |
|
|
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1) |
|
|
(e) Date position held/dealing undertaken For an opening position disclosure, state the latest practicable date prior to the disclosure |
4 November 2026 |
|
(f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” |
YES / NO / N/A If YES, specify which: |
2. INTERESTS AND SHORT POSITIONS
If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.
Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
(Note 2)
|
Class of relevant security |
|
|||
|
|
Interests |
Short positions |
||
|
Number |
% |
Number |
% |
|
|
(1) Relevant securities owned and/or controlled |
10,455,414 |
1.99 |
0 |
0 |
|
(2) Cash-settled derivatives |
0 |
0 |
0 |
0 |
|
(3) Stock-settled derivatives (including options) and agreements to purchase/ sell |
0 |
0 |
0 |
0 |
|
Total |
10,455,414 |
1.99 |
0 |
0 |
All interests and all short positions should be disclosed.
Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
|
Class of relevant |
Purchase/sale |
Number of |
Price per unit |
|
€0.10 ordinary shares |
Sale |
40,000 |
EUR 1.296 |
(b) Cash-settled derivative transactions
|
Class of |
Product |
Nature of dealing |
Number of |
Price |
|
|
|
|
|
|
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
|
Class of |
Product |
Writing, purchasing, selling, varying |
Number |
Exercise |
Type |
Expiry |
Option |
|
|
|
|
|
|
|
|
|
(ii) Exercise
|
Class of |
Product |
Exercising/ |
Number of |
Exercise |
|
|
|
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 3)
|
Class of |
Nature of dealing |
Details |
Price per unit (if |
|
|
|
|
|
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
|
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer. Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none” |
|
|
(b) Agreements, arrangements or understandings relating to options or derivatives
|
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. |
|
|
(c) Attachments
|
Is a Supplemental Form 8 attached? |
NO |
|
Date of disclosure |
05/11/2026 |
|
Contact name |
Siobhán McSorley |
|
Telephone number |
+353 1 592 1077 |
Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 3 minutes ago Morgan Advanced Materials
- 21 minutes ago Surgical Innovations Group
- 37 minutes ago Supermarket Income Reit
- 52 minutes ago British American Tobacco
- 4 hours ago ASA International Group